⌘K

Home/Filings/4/0001209191-20-064450

4//SEC Filing

CHALMERS DEREK T 4

Accession 0001209191-20-064450

CIK 0001346830other

View on SEC.gov Company Profile

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 4:58 PM ET

Size

4.7 KB

Accession

0001209191-20-064450

Insider Transaction Report

Form 4

Period: 2020-12-16

Cara Therapeutics, Inc.CARA

CHALMERS DEREK T

DirectorPresident & CEO

Transactions

Sale
Common Stock
2020-12-16$14.95/sh−5,000$74,750→ 928,921 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cara Therapeutics, Inc.

CIK 0001346830

Entity typeother

Related Parties

1

filerCIK 0001166287

Filing Metadata

Form type: 4
Filed: Dec 17, 7:00 PM ET
Accepted: Dec 18, 4:58 PM ET
Size: 4.7 KB

View on SEC.gov